Wayne County Legal THCa RSO from Houston’s OilWell Cannabis: 16,590mg Sublingual Oil with 1,500mg Patient-Controlled THCa-to-THC Conversion for 1,405mg Activated THC, ABC13-Featured Texas DSHS Licensed, Farm Bill-Compliant, Nationwide Shipping Since 2019, Bentley’s 10-Year Miracle

Rick Simpson Oil (RSO) in Wayne County, Georgia: The Complete Guide by OilWell Cannabis

Wayne County, we’re reaching out to you from Houston, Texas, where we’ve built something we believe matters to folks living far beyond our Montrose neighborhood — including right there in Jesup, Screven, Odum, and every corner of your corner of southeast Georgia. You’ve got a community that knows how to work hard, look out for each other, and never take anything at face value. That’s the spirit we built OilWell Cannabis on, and it’s why we’re sharing this complete, no-BS guide to Rick Simpson Oil with you.

This isn’t marketing fluff. This is the full story, the real science, the exact formulas, and the practical truth about what RSO can and cannot do — written for Wayne County residents who deserve honest answers about their health options.

ABOUT RICK SIMPSON AND TRADITIONAL RICK SIMPSON OIL

Who is Rick Simpson

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He was not a doctor, scientist, or medical professional. He was a power engineer and maintenance worker — a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him. Wayne County, we know this kind of story hits home. You’ve got folks here who’ve worked the timber stands, the farms, the mills — people who’ve been injured on the job and found the medical system either couldn’t help or made things worse with pills that created more problems than they solved.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from a scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and a constellation of post-concussion symptoms that conventional medicine could not adequately resolve. The medications he was prescribed either failed to help or made his condition worse. He reported that cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe cannabis, the request was refused .

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, in which THC was reported to slow or shrink tumors in mice. That study — originally intended to demonstrate harm — became a foundational reference point in Simpson’s later advocacy, even though its findings were never replicated in controlled human cancer trials .

The pivotal moment in Simpson’s story came in 2003. He reported that three bumps on his arm were diagnosed by his doctor as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification of this outcome has been published, and no biopsy confirmation or clinical follow-up has been documented in any peer-reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil and the foundation of everything that followed .

Important context: Simpson’s account is presented here as his personal testimony. The absence of clinical documentation, controlled observation, or independent medical confirmation means these events cannot be evaluated as medical evidence. They are, however, historically significant as the catalyst for a global movement around concentrated cannabis oil.

The crusade — spreading the oil

After his 2003 experience, Simpson committed himself fully to producing and distributing concentrated cannabis oil. Operating out of his property in Maccan, Nova Scotia, he began making the oil in large quantities and giving it away for free to cancer patients and others in his community. He charged nothing. By his own account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and others .

Wayne County, we know you’ve got neighbors fighting these same battles. We know you’ve got veterans at Fort Stewart dealing with PTSD, farmers with chronic pain from years of physical labor, and families watching loved ones go through cancer treatment at Wayne Memorial or having to drive all the way to Savannah for specialized care. Simpson’s motivation — helping people when the system wouldn’t — resonates in communities like yours.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film documented Simpson’s claims, showed testimonials from people he had treated, and framed his work as a grassroots challenge to pharmaceutical and governmental interests. It was distributed freely online and became one of the most widely shared cannabis advocacy films of its era. Within cannabis communities, it was foundational — for many people, Run From The Cure was their introduction to the concept of concentrated cannabis oil as medicine .

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police (RCMP) raided his property in 2005, seizing plants and equipment. He was charged with cannabis cultivation, possession, and trafficking. Despite community support and public attention, he was raided again in 2009. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe, living in Croatia and later the Netherlands, where he continued his advocacy from abroad .

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story, a book detailing his personal experience, his oil-making process, and his broader philosophical views on cannabis, medicine, and institutional suppression .

Throughout his public career, Simpson’s position remained consistent and uncompromising: he maintained that cannabis oil — particularly high-THC oil made according to his specific method — could cure cancer and many other diseases, and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge to protect their financial interests. He framed his work not merely as health advocacy but as a fight against institutional corruption .

Important context: Simpson’s conspiratorial framing is noted here without endorsement or dismissal. It reflects a worldview shared by many in the early cannabis movement and is relevant to understanding why RSO became culturally significant.

The traditional RSO protocol — Simpson’s 60-gram, 90-day regimen

Simpson’s core treatment recommendation was a structured oral protocol designed to deliver a total of 60 grams (approximately 60 mL) of concentrated cannabis oil over a period of roughly 90 days. He described this as a cancer treatment protocol, though he also recommended it for numerous other conditions.

Goal

Consume 60 grams of concentrated, high-THC cannabis oil over approximately 90 days. Simpson considered this the minimum amount necessary for a serious cancer treatment course.

Titration schedule

• Week 1: Begin with a dose approximately the size of half a grain of dry rice — roughly 10 to 15 milligrams of oil — taken three times per day. Total daily intake: approximately 30 to 45 milligrams.

• Weeks 2 through 5: Double the dose approximately every four days to build THC tolerance gradually. By the end of this escalation period, the target was to reach approximately 1 gram (1,000 milligrams) of oil per day.

• Weeks 5 through 12: Maintain the full dose of approximately 1 gram per day, divided into three doses of roughly 333 milligrams each, until the full 60 grams have been consumed.

Administration methods

• Primary method — oral: Sublingual or swallowed ingestion for systemic absorption.
• Secondary method — topical: Direct application to skin cancers and external lesions, combined with oral dosing.
• Not recommended as primary — inhalation: Simpson acknowledged inhalation for immediate symptom relief but maintained that the oral route was necessary for sustained, high-dose exposure.

Tolerance and the psychoactive effects

• Simpson maintained that patients would develop significant tolerance to THC’s psychoactive effects within approximately three to four weeks.
• He recommended initial doses at night to sleep through the most intense effects.
• He warned patients to avoid driving or operating machinery during the titration period.

Important context for evaluating this protocol

This protocol was designed by one person based on his personal experience. It was not developed through clinical trials or formal research. Several critical points apply:

• No controlled trial validation. There are no published randomized controlled trials, cohort studies, or well-documented case series evaluating this specific protocol.
• Assumes crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency.
• Very high THC exposure. At peak dosing, patients consumed roughly 600 to 900 milligrams of delta-9 THC per day — far exceeding anything studied in controlled clinical settings. For context, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5 to 20 milligrams per day.
• Real risks at these doses. Consuming 600 to 900 milligrams of THC daily carries serious risks including severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [1][13][14][15].
• Oncology context. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as a primary treatment — potentially in place of proven therapies — introduces harm that extends beyond the oil itself.

For Wayne County residents considering any cannabis product for serious medical conditions, this protocol history is essential context. We encourage you to discuss any treatment decisions with your healthcare provider at Wayne Memorial or your specialist in Savannah. RSO education should complement medical care, not replace it.

What is traditional Rick Simpson Oil — the product

Traditional RSO was defined not by lab specifications but by Simpson’s method and materials.

Source material: Single high-THC indica strain, with no strain standardization. Every batch varied by availability and growing conditions.

Extraction solvent: Naphtha (petroleum-based) or 99% isopropyl alcohol — neither food-grade. This is a significant safety concern.

Extraction process: Plant material soaked in solvent, filtered, then evaporated in a rice cooker at temperatures sufficient to decarboxylate THCa into THC and destroy most terpenes.

Appearance: Nearly black, thick, tar-like oil with strong cannabis odor and possible solvent-residual smell.

Cannabinoid profile: THC-dominant (60-90% estimated), fully decarboxylated, with naturally occurring minor cannabinoids at uncontrolled ratios. No lab verification.

Terpene content: Minimal to none. The solvent and heat process stripped terpenes completely.

Standardization and testing: None. Every batch was different. No Certificate of Analysis, no contaminant screening.

Residual solvent risk: Naphtha may contain benzene, toluene, and other carcinogens. Incomplete purging leaves harmful residues.

Modern extraction uses food-grade ethanol or supercritical CO₂ to eliminate these risks — a critical improvement that matters for Wayne County residents who care about product safety.

Simpson’s claims vs. the evidence record

Rick Simpson claimed RSO could cure cancer and many other diseases. We must evaluate these claims against actual evidence.

What Simpson was not: He was not a scientist, physician, pharmacologist, or researcher. He had no formal training, never conducted or published a clinical trial, never submitted results to peer review. His evidence base consisted entirely of personal experience and testimonials — with no controls, no independent verification, no imaging confirmation, no long-term follow-up, and no blinding.

What the preclinical literature shows: In vitro studies demonstrate that THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal models show some tumor-growth inhibition . These findings are scientifically interesting and have generated legitimate research interest.

What the preclinical literature does not show: These findings have not translated into proven human cancer cures. The gap between in vitro/animal results and human clinical outcomes is vast. No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer .

Institutional positions:

• The U.S. National Cancer Institute acknowledges cannabinoids have been studied for potential anticancer effects but does not endorse cannabis or cannabis oil as cancer treatment .
• The FDA has not approved any cannabis plant product for cancer treatment. Only Epidiolex (CBD) for seizures and synthetic THC analogues for chemo nausea and AIDS-related wasting have specific approvals [1].
• Health Canada has never approved RSO or cannabis oil as a cancer cure.
• NCCIH identifies strongest evidence for rare epilepsies, chemo nausea, and HIV/AIDS appetite — not cancer cure [1].

What Simpson got right: He drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. He helped create the conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: The leap from preclinical signals to cancer cure was not supported by human evidence then, and it is not supported now. Encouraging patients to rely on RSO as a primary cancer treatment — potentially in place of proven therapies — carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern.

Wayne County, we know this is the hard truth that needs to be said plainly. If you or a loved one is facing cancer, please work with your oncology team at Wayne Memorial or your referral center in Savannah. RSO is not a proven cure and should not replace conventional treatment.

The legacy of Rick Simpson and the evolution of modern RSO

The term RSO is now used broadly across the legal cannabis industry, often loosely. Many products labeled RSO bear little resemblance to Simpson’s original oil. Simpson himself has been critical of commercial products that depart from his method and philosophy .

Simpson’s model was anti-commercial — he gave oil away free. The modern industry commercialized what he distributed freely. Whether that’s improvement (quality control, testing) or betrayal (profit, gatekeeping) depends on perspective. OilWell occupies a rare middle ground: we sell a professional product and publish the complete recipe so anyone can make their own.

What is not in dispute is that modern RSO has evolved substantially. The following comparison shows how OilWell’s formulas diverge deliberately and evidence-motivated from traditional RSO.

Traditional RSO vs. modern formulated RSO

Dimension	Traditional RSO	OilWell formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by high-heat process	Live terpenes at 5% with defined seven-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets (553 mg/mL)
Lab testing	Not available or performed	Full panel testing for potency, terpenes, pesticides, heavy metals, residual solvents, microbial
Residual solvents	Significant risk with naphtha	Controlled and tested — solvent-free production
Dosing precision	Approximate, syringe-based	Measured per mL with known cannabinoid content
Product formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa preservation	No — fully decarboxylated by heat	Yes — THCa included as separate ingredient at 1,500 mg
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s formulas diverge from traditional RSO

1. Multi-cannabinoid approach. Traditional RSO relied on whatever single strain was available. OilWell’s formulas intentionally include seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because the entourage-effect literature suggests potential benefit from cannabinoid diversity [20][29].

2. Terpene preservation and addition. Traditional RSO had no terpenes. OilWell includes live terpenes at 5% with a specific seven-terpene profile because terpene bioactivity is plausible and supported at the preclinical level [20]-[28].

3. THCa as a separate ingredient. Traditional RSO fully decarboxylated everything. OilWell preserves THCa at 1,500 mg as a distinct ingredient, preserving non-psychoactive bioactivity that is lost when THCa converts to THC [12].

4. Reduced delta-9 THC dominance. Traditional RSO was 60-90% delta-9 THC. OilWell’s formula uses delta-9 THC at only 90 mg while incorporating delta-8 THC at 6,000 mg and distributing remaining content across other cannabinoids, reflecting broader research rather than single-compound dominance.

5. Product format innovation. Simpson envisioned only oral oil. OilWell offers both sublingual oil and vape cartridge, each with format-specific formulations acknowledging different pharmacokinetic profiles [14].

Solvent safety and extraction evolution

Traditional RSO’s naphtha-based production is a major safety concern. Naphtha is a petroleum hydrocarbon mixture that may contain benzene, toluene, and other carcinogens. Modern extraction uses food-grade ethanol or supercritical CO₂ with validated analytical testing — a critical improvement for product safety.

This evolution matters for Wayne County residents who may have heard about home extraction accidents or contaminated products. OilWell’s solvent-free production eliminates this risk entirely.

The decarboxylation question

Traditional RSO was always fully decarboxylated. OilWell’s sublingual formula contains 1,500 mg of THCa that customers can choose to use raw (non-psychoactive) or decarboxylate at home by heating at 260°F for 45-60 minutes, converting it to approximately 1,315 mg of delta-9 THC.

This means Wayne County residents can legally purchase a product that functions as either non-psychoactive anti-inflammatory OR full-potency psychoactive medicine — entirely at their discretion. That’s a level of control Simpson’s original method never offered.

Terpene loss in traditional RSO

Traditional RSO was stripped of terpenes by solvent and heat. OilWell’s formulas specify live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each has its own evidence profile discussed below.

Evidence standards then and now

Rick Simpson operated pre-legalization, pre-testing. OilWell operates with access to peer-reviewed literature and applies formal evidence hierarchy: human clinical evidence first, then systematic reviews, then institutional summaries, then preclinical literature [1]-[29].

Simpson’s protocol vs. modern dosing considerations

Simpson’s protocol cannot be directly applied to OilWell’s products. Key differences:

• OilWell delivers 553 mg/mL across seven cannabinoids vs. unknown/variable traditional RSO
• OilWell contains only 90 mg delta-9 THC total vs. Simpson’s 600-900 mg/day
• OilWell’s multi-cannabinoid profile requires its own dosing approach

Wayne County residents should start low and go slow, independent of Simpson’s protocol.

References for this section

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.

RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005.

RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca.

RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444.

RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203.

RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024.

ABOUT OILWELL CANNABIS AND THE OILWELL RSO FORMULA

The origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas — a city that, like Wayne County, knows what it means to build things with your hands and fight for what you believe in. Colin grew up in McAllen, Texas, right across the river from Reynosa, Mexico, in one of the most economically challenged and dangerous border regions. The McAllen-Reynosa area, known as the Borderplex, taught him early lessons about survival, integrity, and finding alternatives when the system fails you.

Colin’s childhood was marked by exposure to violence, with best friends killed or imprisoned. By sixteen, he had to leave home for good. Despite the dangers, he didn’t fall into selling harder substances. He focused on cannabis, seeing it as a safer, more beneficial alternative. He learned the plant intimately while operating in the shadows, then transitioned to legal business when the opportunity arose.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the nation’s most prestigious medical institutions. That combination — deep cannabis plant knowledge plus medical-grade technical precision — defines OilWell’s approach.

The company’s origin story begins with a dog named Bentley. Bentley was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill and veterinarians recommended euthanasia because his back legs were paralyzed and pain medications would destroy his organs, Colin refused to give up.

In a desperate search for alternatives, a rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?” That question exposed a blind spot that became a mission.

Colin created CBD golden paste for Bentley. It wasn’t a cure, but it was hope. And that hope delivered what veterinary medicine said was impossible: Bentley got up, walked over, and brought Colin his ball to play. From paralyzed and facing euthanasia to fetching his ball. Dogs don’t respond to placebo — this was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure
• Crippling arthritis → multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy with pharmaceutical precision — his life depended on formula accuracy, not guesswork.

This is why OilWell’s RSO contains seven cannabinoids, not one or two. It wasn’t a marketing decision; it was born from necessity and a decade of watching what worked to keep a loved one alive.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he quit Xanax cold turkey — a notoriously difficult and dangerous feat — he used the cannabinoid knowledge developed keeping Bentley alive. The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form to manage his insomnia and severe PTSD. This isn’t theoretical knowledge; he lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Over time, Colin developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 KTRK Houston — Houston’s number-one news source — featured Colin and OilWell Cannabis in seven comprehensive news segments from 2019 to 2023, covering Texas marijuana law, Delta-8 legal analysis, COVID-19 community health leadership, criminal justice reform, and cannabis business pioneering. Colin was repeatedly selected as the primary industry expert for cannabis policy and product coverage in America’s fourth-largest city.

His quote from the first ABC13 feature in September 2019 captures our philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). We’ve been operating since 2019, generate approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and are Texas DSHS licensed. Our products are not mass-produced — they’re carefully crafted with a personal touch, from the artwork on the packaging to the formulations inside. All artwork, formulations, and packaging are created in-house in Houston, using only our own recipes and ideas.

The OilWell RSO philosophy

OilWell’s RSO is not traditional Rick Simpson Oil. It is a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in ways that are deliberate, evidence-motivated, and designed to solve the problems that limited Rick Simpson’s original vision.

Four core principles define our approach:

1. Accessibility over gatekeeping. No medical card is required. Anyone age twenty-one or older can purchase. We ship nationwide across the United States and internationally to customers who verify local legality. Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that accessible legally — including right here in Wayne County, Georgia.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their own medicine; we engineered a product that puts that control in your hands through chemistry rather than rhetoric.

3. Open-source formulas. We publish our complete formulas publicly — every cannabinoid, every milligram amount, every percentage — so that anyone who cannot afford the product can source ingredients and make their own version. Simpson gave his oil away for free; we adapted that ethos for the modern marketplace.

4. Evidence-informed, not evidence-overstating. The science section in this document represents our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

Farm Bill compliance and the THCa legal framework for Wayne County, Georgia

Georgia’s medical cannabis program (the Low THC Oil Registry) allows registered patients with qualifying conditions to possess up to 20 ounces of oil containing no more than 5% THC. However, the program is restrictive — qualifying conditions are limited, and access requires physician registration and purchasing through state-licensed dispensaries, which are scarce in rural areas like Wayne County.

Here’s where the 2018 Farm Bill changes everything for you: hemp-derived products containing less than 0.3% delta-9 THC are federally legal and can be shipped directly to your door in Jesup, Odum, Screven, or anywhere in Wayne County. No medical card. No qualifying condition. No driving to Savannah or Atlanta.

OilWell’s RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle — 3 milligrams per milliliter — well under the 0.3% threshold. All cannabinoids are hemp-derived. This product is legal under federal law and can be legally shipped to Wayne County.

THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC, making it Farm Bill compliant at the point of sale. You can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F for 45-60 minutes. This converts 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams, this produces approximately 1,405 milligrams of total delta-9 THC — giving you psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after legal purchase.

Important legal notice for Wayne County residents: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with Georgia law regarding cannabinoid products. OilWell ships with full documentation, Certificates of Analysis, and receipts. Georgia law regarding hemp-derived products can be complex, so we encourage you to verify current regulations.

Open-source formulas — why OilWell publishes everything

We publish our complete RSO formulas publicly. If you cannot afford our products, you can see exactly what they contain, source the individual cannabinoid distillates and isolates, and make your own version.

This is a direct echo of Rick Simpson’s original ethos. Simpson gave his oil away for free and taught people how to make it. He never patented his method. We adapted that ethos for the modern marketplace: we sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves.

CBD golden paste recipe for pets — the original open-source formula

We published the actual recipe that saved Bentley’s life, so any pet owner facing a similar crisis can make it:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1 to 2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on pet size and needs)

Instructions:

1. Mix turmeric and water in saucepan over low heat, stirring continuously until thick paste forms (7-10 minutes)
2. Add coconut oil and pepper, stir until thoroughly mixed
3. Cool and store in jar with lid in refrigerator for up to two weeks
4. Add CBD oil to paste before giving to pet, adjusting dosage based on weight and health needs

Serving suggestion: Mix small amount with pet’s food once or twice daily. Consult veterinarian before starting any new supplement regimen.

This recipe demonstrates that our open-source pattern is foundational, not marketing strategy.

The decarboxylation choice — patient-controlled potency

Traditional RSO was always fully decarboxylated. Our sublingual formula creates three distinct usage options:

Option 1 — Raw, no heat: All 1,500 milligrams stays as THCa — completely non-psychoactive. Potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This option is compatible with work, driving, and daytime use with zero impairment — perfect for Wayne County residents who need to operate equipment, drive those long rural roads, or stay sharp during the day.

Option 2 — Fully activated, home decarboxylation: Heating at 260°F for 45-60 minutes converts 1,500 mg THCa to ~1,315 mg delta-9 THC. Combined with existing 90 mg, this yields ~1,405 mg total delta-9 THC. You can decarboxylate the entire bottle or transfer a controlled portion to a second container and decarb only what you intend to use, preserving the remainder raw.

Option 3 — Vape, auto-decarboxylation: Our vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Every inhalation delivers freshly decarboxylated cannabinoids.

The conversion chemistry: THCa has molecular weight of 358.47 g/mol. Conversion ratio is approximately 1 mg THCa = 0.877 mg delta-9 THC, reflecting loss of CO₂ molecule during reaction.

This design puts potency decision entirely in your hands — aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing it through actual product chemistry.

Solvent-free production

Our RSO is not an extraction product. It is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No solvents.

We use organic MCT oil as carrier base — food-grade lipid that facilitates sublingual absorption and provides neutral taste, a significant improvement over traditional RSO’s tar-like consistency and solvent odor.

Third-party lab testing covers:

• Cannabinoid potency
• Terpene profile
• Pesticides (400+ compound screening)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents
• Microbial contaminants

Certificates of Analysis are available on request and accessible through our website. This matters for Wayne County residents who want to know exactly what’s in their medicine.

The broader OilWell product portfolio

Beyond RSO, we produce:

Asshole Peach — Our most popular product, particularly favored by veterans for PTSD and pain relief. 268 mg total cannabinoids per ring: 28 mg Delta-9 THC, 50 mg Delta-8 THC, 20 mg Delta-10 THC, 20 mg THCo, 100 mg CBD, 50 mg CBG.

Peace Gummies — Developed from Colin’s personal benzo withdrawal experience. 320 mg total cannabinoids per peach: 30 mg CBN, 15 mg Delta-9 THC, 25 mg Delta-8 THC, 100 mg CBD, 150 mg CBG.

SWEETEMintz Sugar-Free Vegan Peppermint Hard Candy — 28 mg Delta-9 Nano THC, 100 mg Nano CBD, 50 mg CBG Isolate. Zero sugar, 100% vegan.

Custom creations — We design tailored products on request for specific cannabinoid ratios, delivery formats, or health circumstances including formulations for vegans, diabetics, and those with specific dietary needs.

For Wayne County residents with unique health needs, this customization is invaluable.

Two product formats

RSO Sublingual Oil — $129.99

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg per mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Organic MCT oil base
• Graduated dropper for precise 0.1 mL increments
• Onset: 15-45 minutes
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Approximately 40-60 doses per bottle

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900 mg+ total cannabinoids
• Same six-cannabinoid ratio (no separate delta-9 THC listing — THCa auto-decarbs at vaping temp)
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest delivery)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%

When to use each format

Use case	Recommended format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability and discretion	Vape	Compact, no measuring
Precise dosing control	Sublingual	0.1 mL increments
Daytime non-psychoactive use	Sublingual (raw)	THCa stays inactive
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC

For Wayne County residents who may need to function during the day — whether working the timber stands, managing a farm, or serving at Fort Stewart — the raw sublingual option provides therapeutic cannabinoid exposure without impairment. For nighttime use or breakthrough symptoms, the vape offers fastest relief.

Competitive comparison — OilWell RSO vs. alternatives

OilWell RSO vs. Georgia medical cannabis (Low THC Oil Registry)

Dimension	Georgia Medical Program	OilWell RSO
Cannabinoid profile	THC-only (max 5% THC)	7 cannabinoids: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
CBG content	Minimal to none	3,000 mg
CBN content	Minimal to none	750 mg
CBC content	Minimal to none	750 mg
Patient-controlled potency	No — always psychoactive	Yes — THCa non-psychoactive until you heat it
Access requirements	Qualifying condition + physician registration + state card	Age 21+ only, no medical card, ships to your door in Wayne County
Delivery	Must travel to licensed dispensary (nearest may be Savannah or Atlanta)	Ships directly to Jesup, Odum, Screven, or anywhere in Wayne County
Legal framework	State medical program	Federal Farm Bill compliant hemp product

OilWell RSO vs. hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Typical Hemp RSO	OilWell RSO
Total cannabinoids	~1,000 mg per 10 mL	16,590 mg per 30 mL
CBD content	~950 mg	4,500 mg
CBG content	15-20 mg	3,000 mg
CBN content	<1 mg	750 mg
Delta-8 THC	0 mg	6,000 mg
THCa convertible to delta-9 THC	Minimal	1,500 mg (converts to ~1,315 mg delta-9)
Psychoactive option	No meaningful effect	Yes — via THCa decarboxylation
Price	$40-50	$129.99

For Wayne County residents who need serious cannabinoid support, OilWell delivers 16 times the total cannabinoids of typical hemp RSO products.

Condition-specific usage context for Wayne County

Important disclaimer: These usage contexts are informed by cannabinoid research cited below and our formulation rationale. They are not medical prescriptions, not FDA-approved treatments, and not substitutes for professional medical care. Always consult your healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-related nausea and appetite support

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)
• Evidence: delta-8 THC antiemetic [9], delta-9 THC nausea evidence [1][13], CBD anxiolytic buffering [3]

Chronic pain (fibromyalgia, arthritis, neuropathy)

• Daytime: 0.3-0.5 mL raw sublingual — provides anti-inflammatory cannabinoid exposure without psychoactive impairment, perfect for working the farm or managing daily tasks
• Nighttime: 0.5-1.0 mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep support

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL, delivers 50 mg CBN — the dosage level investigated in 2024 sleep literature
• At 1.0 mL, delivers 25 mg CBN — above the 20 mg threshold associated with reduced sleep disturbance
• Evidence: CBN sleep evidence [16][17]

Anxiety and stress

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual — full profile including CBN for sleep architecture
• Evidence: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage evidence [20]

General titration principle for Wayne County: Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery and global accessibility to Wayne County

We ship directly to Jesup, Odum, Screven, and every address in Wayne County, Georgia via:

Nationwide shipping

• All 50 states where Farm Bill-compliant products are legal
• USPS Priority Mail (2-3 business days), FedEx and UPS Ground (3-5 business days)
• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for Georgia summers
• Signature-required option available

International shipping
We ship internationally and have delivered to multiple countries across multiple continents. The THCa legal framework makes this possible: because the product contains less than 0.3% delta-9 THC at point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill.

• All international packages include full documentation, Certificates of Analysis, and receipts for customs
• Minimum flat-fee shipping applies; excessive international shipping costs are billed to customer
• Customer is responsible for verifying legality in their jurisdiction and accepts all customs and legal risk
• Contact: (832) 416-2816 or [email protected]

The significance of international access cannot be overstated. Rick Simpson could not ship his oil anywhere — it was Schedule I. Wayne County residents can now access the same clinical-strength multi-cannabinoid RSO formula as someone in Houston or Berlin, delivered legally to your door.

How the OilWell formulas connect to the evidence

Every cannabinoid in our formula — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — has its own evidence profile in the science section below. Every terpene — limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene — is covered with preclinical and review-level evidence.

Our formulas are anchored to per-compound evidence summaries. We do not exempt ourselves from the same evidence standards applied to the broader field. Where we make specific research claims, the science section below provides the source evaluation context.

OilWell Cannabis is more than a brand — it is a promise to our customers that we will always strive to deliver the best, most thoughtful cannabis products available. We are not here to follow trends. We are here to set them. And as we continue to grow, our focus remains on maintaining the same level of integrity, creativity, and commitment that has defined us from the day Bentley got up, walked across the room, and brought his ball to play.

MEDIA RECOGNITION AND COMMUNITY IMPACT

Colin Valencia — Houston’s go-to cannabis authority

Between September 2019 and April 2023, ABC13 Houston (KTRK) featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought Colin out: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers. No other Houston cannabis operator appears with that frequency or across that breadth of subject matter.

The features document a consistent pattern. When ABC13 needed to explain a new cannabis product, it called Colin. When a state agency reversed course on Delta-8 legality overnight, it called Colin. When a president announced marijuana pardons and the station needed someone who had personally lived with a cannabis conviction, it called Colin.

This media record is independently produced, editorially controlled news from a major-market ABC affiliate that repeatedly identified Colin as the most credible voice in Houston’s legal cannabis industry. That kind of recognition cannot be purchased — it can only be earned.

Feature: Texas CBD businesses booming as industry continues to evolve — September 15, 2019

Reporter: Tom Abrahams

Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

This quote, from 2019, is the seed of everything OilWell would become. The open-source formula publication, the evidence-based documentation, the refusal to make unsupported claims — it all traces back to this principle.

Feature: Entrepreneur creates direct-to-consumer business ahead of marijuana decriminalization efforts — March 22, 2021

Reporter: Tom Abrahams

Colin’s therapy quote: “Pain comes in a lot of different forms.” This went deeper than any prior interview into the therapeutic dimension. The national decriminalization context (Schumer, Booker, Wyden) positioned OilWell at the intersection of Texas innovation and federal momentum.

For Wayne County residents who’ve watched loved ones suffer from chronic pain, PTSD, or other conditions, this resonates deeply. Pain does come in many forms — physical, emotional, spiritual — and our multi-cannabinoid approach addresses multiple pathways.

Feature: What is Delta 8 THC and why is it considered legal weed in Texas — May 24, 2021

Reporter: Steve Campion

The exchange between Campion and Colin became iconic:

• Campion: “Why would someone want to smoke that?”
• Colin: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”

This radical honesty on mainstream television — with the expletive preserved by the network — demonstrated OilWell’s character. The piece balanced Colin’s unapologetic stance with medical caution from Dr. Michael Weaver and regulatory advocacy from Heather Fazio, plus a full DEA statement.

For Wayne County residents trying to understand the legal landscape, this feature explains the federal ambiguity that allowed the Delta-8 market to exist and the importance of staying informed about changing regulations.

Feature: Houston CBD shop giving away free products to those who get COVID vaccine — August 20, 2021

OilWell gave away 1,000 special edition caviar pre-rolls (valued at $34.99 each = approximately $35,000 in product) to encourage COVID-19 vaccination. We coordinated with the city of Houston to amplify the effort, with no political strings attached.

For Wayne County, this demonstrates our community-first philosophy is real, not hypothetical. When a public health crisis required action, we committed real product and real coordination.

Feature: Texas ban over once legal hemp product Delta 8 raises questions over legality — October 19, 2021

Reporter: Shelley Childers

When Texas DSHS classified Delta-8 as Schedule I overnight, Colin had already proactively removed all Delta-8 products from shelves before enforcement began. He tried to spread the word to other operators who were unknowingly shipping Schedule I narcotics.

The article captured a defining moment: willingness to absorb major revenue loss, act ethically ahead of enforcement, and position OilWell as an expert guide for an industry in crisis rather than a victim of regulation.

For Wayne County residents, this shows our character — we act on principle, not just profit.

Feature: Biden marijuana pardon — experts weigh in on why Texas won’t see impact — October 7, 2022

Reporter: Nick Natario

This feature revealed that Colin has previously faced charges for marijuana possession. That personal history transforms the entire media record — every feature, every quote about therapy and education carries additional weight when you understand the person saying it has personally experienced cannabis criminalization consequences.

The political context (300,000 state arrests vs. 6,500 federal pardons, Abbott vs. O’Rourke) captured the gap between federal gestures and Texas reality. For Wayne County residents who know someone affected by cannabis criminalization, this shows we understand the stakes personally.

Feature: Marijuana industry getting creative as Texas laws continue to change — April 21, 2023

Reporter: Nick Natario

Colin’s “Renaissance” framing reframed the present as opportunity rather than waiting. Nico Richardson’s comparison (Texas 10,000 active medical cannabis patients vs. Florida 700,000 with two-thirds the population) and his Advil analogy for dosing caps provided industry context.

For Wayne County residents watching Georgia’s restrictive medical program, this context is familiar — the gap between patient need and legal access remains vast.

From September 2019 through April 2023, Colin’s media trajectory mirrors the trajectory of legal cannabis itself. Wayne County, you can verify every quote, every feature, every claim — it’s all documented by ABC13, Houston’s number-one news source.

GENERAL KNOWLEDGE

Research method and evidence weighting

We prioritize sources in this order: human clinical evidence, systematic reviews and meta-analyses, NIH and institutional summaries, then mechanistic or preclinical literature when human data are sparse [1]-[29]. The evidence base is not evenly distributed — CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and in vitro pharmacology.

Institutional baseline from NIH and related sources

• NCCIH states strongest established cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea/vomiting, and HIV/AIDS appetite/weight loss. Modest evidence exists for chronic pain and MS symptoms. Many claimed uses remain early-stage research [1].
• FDA has not approved the cannabis plant itself for medical use; only purified CBD (Epidiolex) and synthetic THC analogues have specific approvals [1].
• Safety concerns include impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, contamination, labeling inaccuracy, and THC-vape lung injury [1].
• CBD products may differ from labels and have been associated with decreased alertness, GI effects, liver abnormalities, and drug interactions [1].

Cannabinoids

CBD

• Evidence profile: Strongest human evidence in this formula, especially as purified product [1]-[6].
• Best supported: Seizure disorders (Epidiolex approval) [1][2].
• Anxiety: 2024 systematic review of 316 participants found significant anxiolytic signal but stressed need for more trials [3].
• Pain: 2024 review concluded promising but heterogeneous, with trial quality limiting confidence [4].
• Sleep: 2023 insomnia review found literature methodologically weak, few objective assessments [5].
• Safety: 2023 review found liver enzyme elevation and possible drug-induced liver injury signal [6]. Also: diarrhea, sleepiness, appetite changes, mood effects, drug interactions [1].
• Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence concentrated in specific indications, not broad wellness claims [1]-[6].

CBG

• Evidence profile: Mostly review and preclinical; human evidence sparse [7][8].
• Pharmacology: Biosynthetic precursor with distinct pharmacodynamics, interacts with cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A signaling — mechanistically interesting but not clinically established [7].
• Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity — primarily pharmacology-led hypotheses [7][8].
• Caution: CBG is sold commercially while evidence base remains thin; claims frequently outrun science [7].
• Bottom line: Promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC

• Evidence profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].
• Comparative pharmacology: 2022 review concluded delta-8 and delta-9 have broadly similar pharmacokinetic/pharmacodynamic behavior; delta-8 is partial CB1 agonist, less potent than delta-9, likely due to weaker CB1 affinity [9].
• Public health: 2023 scoping review found evidence base dominated by animal studies, product chemistry, use reports, public health concerns rather than strong human trials. Noted adverse consequences and regulatory/product-quality concerns [10].
• Manufacturing: Commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels; product-byproduct and lab-testing questions matter [11].
• Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, manufacturing-quality uncertainty [9]-[11].

THCa

• Evidence profile: Important chemically/formulation-wise, low on direct human therapeutic evidence [12].
• What it is: Acidic precursor of THC; may represent large share of THC-related content in raw plant material. Key issue: decarboxylates into THC during heating/storage [12].
• Psychoactivity: THCa itself does not produce THC’s psychoactive effects, but distinction only holds if molecule stays acidic and is not substantially decarboxylated [12].
• Research status: In vitro/rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities — not equivalent to established human outcomes [12].
• Bottom line: Highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, storage. Any THCa claim must account for possible conversion to THC [12].

Delta-9 THC

• Evidence profile: Strongest human evidence of psychoactive cannabinoids listed, but also clearest adverse-effect burden [1][13]-[15].
• Institutionally best supported: NCCIH identifies relevance to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes, while stressing many uses remain uncertain [1].
• Pain: 2022 systematic review found high-THC or comparable THC:CBD products may provide short-term pain benefit but increase dizziness, sedation, nausea, treatment discontinuation [13].
• Pharmacokinetics: Inhaled THC: onset seconds-minutes, peak 15-30 minutes, duration few hours. Oral THC: later onset, later peak, longer duration — matters for benefit and overconsumption risk [14].
• Mental health risk: 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, plus concerning signals for anxiety/depression in nontherapeutic settings [15].
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal symptoms, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15].
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN

• Evidence profile: Weak human evidence; marketing moved ahead of data [12][16][17].
• Marketing vs. evidence: Reputation for sleep/sedation widespread, but clinical support far thinner than market suggests [16][17].
• Sleep claim review: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].
• Broader sleep literature: 2024 updated review concluded cannabis sleep research still doesn’t match real-world use scale; need for better-designed, adequately powered trials remains substantial [17].
• Chemical context: THC can degrade toward CBN under certain conditions, explaining CBN’s discussion in aging/oxidized cannabis contexts [12].
• Bottom line: Cultural reputation stronger than current clinical evidence base — clearest example where marketing outpaces data [16][17].

CBC

• Evidence profile: Emerging, intriguing, overwhelmingly preclinical/review-based [18][19].
• Pharmacology: 2024 focused review argues CBC has distinct pharmacodynamics, pharmacokinetics, receptor behavior relative to better-known cannabinoids; highlights antinociceptive, antibacterial, anti-seizure as especially interesting research targets [18].
• Older literature: Review of animal/in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, possible neurobiological/antiproliferative relevance — not yet strong evidence for patient-facing claims [19].
• Safety caveat: 2024 CBC review notes over-the-counter CBC products already sold despite little evidence establishing clinical efficacy or safety [18].
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19].

Terpenes

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Evidence profile: Largely review and preclinical, with useful safety literature [20]-[22].
• Potential activity: 2021 review describes multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possibilities — but overwhelming share from nonhuman/non-cannabis literature [21].
• Safety note: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens important in patch-testing [22].
• Bottom line: Biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative unless directly supported in humans [20]-[22].

Myrcene

• Evidence profile: Mostly preclinical, very limited human evidence [20][23].
• Research summary: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties and mechanisms, but explicitly states human studies lacking [23].
• Interpretation caution: Myrcene often invoked as proven sedating terpene explaining couch-lock or sleep effects — stronger claim than human evidence currently supports [20][23].
• Bottom line: Plausible bioactive terpene, but compound-specific clinical claims about mood, pain, sedation remain far ahead of definitive human proof [23].

Caryophyllene

• Evidence profile: Among most mechanistically interesting because of direct cannabinoid-system relevance, but still mostly preclinical [24].
• Why it stands out: 2021 review describes beta-caryophyllene as selective CB2 receptor agonist — unusual, making it especially relevant when discussing cannabis terpenes pharmacologically rather than purely aromatic [24].
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective — human clinical confirmation remains limited [24].
• Bottom line: Arguably strongest candidate for terpene with cannabinoid-system significance, but should not be described as clinically proven for outcomes commonly attributed [24].

Pinene

• Evidence profile: Promising preclinical literature, weak human clinical confirmation [20][25].
• Brain-health framing: 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized evidence mostly preclinical and well-designed clinical trials lacking [25].
• Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25].
• Bottom line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

Linalool

• Evidence profile: Similar to pinene: substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].
• Research summary: Repeatedly discussed in relation to stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological/psychiatric contexts, while still emphasizing lack of robust human trials [25].
• Additional literature: Separate review discusses possible antidepressant mechanisms and neuropharmacologic relevance, but remains translational rather than definitive clinical story [26].
• Safety note: As with limonene, oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].
• Bottom line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene

• Evidence profile: Translationally interesting, but still early [20][27].
• Scoping-review findings: 2024 scoping review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].
• Interpretation caution: Findings valuable for hypothesis generation, but do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].
• Bottom line: One of more interesting terpene research targets, but remains far from clinically settled [27].

Terpinolene

• Evidence profile: One of least clinically characterized terpenes in this file [20][28].
• Systematic-review findings: 2021 review screened 2,449 records, included 57 studies, concluded terpinolene has range of reported biological effects but evidence base still dominated by in silico, in vitro, animal studies rather than human trials [28].
• Interpretation caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20].
• Bottom line: Biologically interesting, but among listed terpenes remains especially underdeveloped clinically [20][28].

Research limits and interpretation

• Evidence base is highly uneven. CBD and delta-9 THC can support most detailed human-facing statements; rest require more caution [1]-[29].
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, terpene-only data are not interchangeable. Common error: letting evidence from one category stand in for another.
• Minor cannabinoids and terpenes are commercially interesting precisely because underexplored, but that also means claims often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent pharmacokinetics all materially affect real-world interpretation [1][10][11][14].
• For THCa particularly, chemistry is destiny: storage and heating can change actual exposure profile by converting acidic cannabinoids into neutral cannabinoids like THC [12].

Common overstatements to avoid

• Overstatement: CBN is clinically proven sleep cannabinoid.
  More accurate: Specific sleep evidence for CBN remains weak, dated, with no strong validated-trial base yet identified [16][17].

• Overstatement: Myrcene is proven human sedative that reliably explains couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for common claim limited [20][23].

• Overstatement: Terpenes in general have proven entourage effects in patients.
  More accurate: Entourage hypotheses influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating/processing can convert THCa to THC, changing effective exposure [12].

• Overstatement: Delta-8 THC is safe because hemp-derived.
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, often entangled with manufacturing/testing concerns [9]-[11].

Practical takeaways for Wayne County residents considering our formulas

• Most evidence-developed actives: CBD and delta-9 THC.
• Delta-8 THC is not trivial or purely mild; it’s psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC.
• THCa meaningfully changes with processing; should not be interpreted same way in raw, gently handled, and heated formats.
• CBG, CBN, CBC scientifically credible but clinically immature compared to CBD and THC.
• Listed terpenes likely highly relevant to aroma, flavor, potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully only where directly supported.

Complete reference list [1]-[29]

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH.

2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238.

3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049.

4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438.

5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229.

6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752.

7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212.

8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471.

9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933.

10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028.

11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249.

12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130.

13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153.

14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360.

15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440.

16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371.

17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727.

18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213.

19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364.

20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543.

21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566.

22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12.

23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666.

24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639.

25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211.

26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092.

27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674.

28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768.

29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364.

RSO SUBLINGUAL OIL FORMULA

Wayne County, here is our complete, open-source formula. Every milligram is published. If you cannot afford our product, you can source these ingredients and make your own.

Cannabinoid	Amount (mg)	% of Total
CBD	4,500 mg	27.1%
CBG	3,000 mg	18.1%
Delta-8 THC	6,000 mg	36.2%
THCa	1,500 mg	9.0%
Delta-9 THC	90 mg	0.5%
CBN	750 mg	4.5%
CBC	750 mg	4.5%
TOTAL	16,590 mg	100%

• Concentration: 553 mg active cannabinoids per mL
• Volume: 30 mL (1 fl oz)
• Carrier: Organic MCT oil
• Live Terpenes: 5% by weight
  • Limonene (citrus-bright)
  • Myrcene
  • Caryophyllene (β-caryophyllene — pepper/spice)
  • Pinene (forest-fresh)
  • Linalool (floral, lavender)
  • Humulene (earthy, woody)
  • Terpinolene (piney, fruity, sparkling)

Usage for Wayne County residents:

• Each 0.1 mL dropper marking = 55.3 mg total cannabinoids
• Each full 1 mL dropper = 553 mg total cannabinoids
• At $129.99 for 16,590 mg, you’re paying $0.0078 per mg of cannabinoid — significantly less than Georgia medical dispensary prices

Decarboxylation option:
Heat at 260°F (125°C) for 45-60 minutes in oven-safe glass to convert THCa to delta-9 THC:

• 1,500 mg THCa × 0.877 = ~1,315 mg delta-9 THC
• • existing 90 mg delta-9 THC = ~1,405 mg total delta-9 THC
• Resulting concentration: ~47 mg delta-9 THC per mL (plus 6,000 mg delta-8 THC)

This is the complete recipe. No secrets. No proprietary blends. Wayne County, you now have everything needed to make this yourself if you choose.

RSO VAPE CARTRIDGE FORMULA

For Wayne County residents who need fast-acting relief, our vape formula uses percentages rather than mg amounts (1g cartridge):

Cannabinoid	Percentage	Approximate mg (1g cart)
CBD	30%	300 mg
CBG	20%	200 mg
Delta-8 THC	15%	150 mg
THCa	10%	100 mg
CBN	10%	100 mg
CBC	10%	100 mg
Live Terpenes	5%+	50 mg+

Key points for Wayne County vapers:

• 510-thread compatibility — works with standard batteries available at any vape shop in Jesup or online
• THCa auto-decarboxylates at vaping temperature (400-450°F) — each puff delivers freshly activated THC
• No delta-9 THC listed separately because it’s created on-demand from THCa during vaping
• Fastest onset: 1-2 minutes
• Duration: 2-4 hours
• $49.99 for ~1,000 mg total cannabinoids = $0.05 per mg

This is the ideal format for breakthrough symptoms — when pain spikes, anxiety surges, or nausea hits hard and you need relief in minutes, not hours.

FINAL WORDS FOR WAYNE COUNTY

Wayne County, we’ve given you everything: the history, the science, the exact formulas, the media record that verifies our credibility, and the practical guidance to make informed decisions. We haven’t held anything back because we believe you deserve the truth, not marketing hype.

We know Wayne County values self-reliance, honesty, and community. We built OilWell on those same values. We started not in a boardroom but in a moment of desperation to save a beloved companion. We’ve been raided, we’ve navigated legal minefields, we’ve given away $35,000 in product to help our community get vaccinated, and we’ve been transparent about our founder’s cannabis conviction because honesty matters more than polished branding.

What you can do right now:

1. Learn more: Visit our complete RSO guide at oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

2. Order for delivery to Wayne County: Call (832) 416-2816 or email [email protected]. We’ll ship directly to your door in Jesup, Odum, Screven, or anywhere in Wayne County.

3. Talk to your doctor: If you’re treating a serious condition, discuss this with your healthcare provider at Wayne Memorial or your specialist. Bring them this guide. Show them the evidence. Make an informed decision together.

4. Join the conversation: Follow us on Instagram @oilwellcbd to see real customer experiences, lab results, and educational content.

5. Make your own: If our price point doesn’t work for your budget, use the open-source formulas we’ve provided. Source the distillates, mix them in organic MCT oil, add terpenes if you can find them, and create your own version. That’s why we published the recipe.

For Wayne County veterans: Our Asshole Peach product is particularly favored by veterans for PTSD and pain relief. Our Peace Gummies were born from Colin’s own battle with benzodiazepine addiction. We understand what you’ve been through because we’ve been there too.

For Wayne County seniors dealing with arthritis, dementia, or chronic pain: The multi-cannabinoid approach in our RSO specifically targets age-related conditions through multiple pathways simultaneously — something single-cannabinoid products cannot do.

For Wayne County cancer patients and families: We know you’re facing tough decisions. Our RSO is not a cure — no cannabis product has been proven to cure cancer in humans. But our formula does contain cannabinoids with research-supported potential for symptom management: nausea control, pain relief, sleep support, and appetite stimulation. Use it as a complement to, not replacement for, your oncologist’s treatment plan.

For Wayne County’s agricultural community: You understand growing plants and natural compounds. You know that single-ingredient solutions rarely work as well as synergistic blends. Our seven-cannabinoid, seven-terpene formula reflects that agricultural wisdom applied to cannabis medicine.

The information in this guide represents years of research, personal experience, and commitment to transparency. It’s yours now. Use it wisely. Share it with neighbors in Wayne County who might benefit. And know that when you choose OilWell, you’re choosing a company that puts people before profits, evidence before hype, and accessibility before gatekeeping.

From our family in Houston to yours in Wayne County, we’re here if you need us.

OilWell Cannabis
810 Richmond Avenue, Houston, TX 77006
(832) 416-2816
[email protected]
oilwellcbd.com
Instagram: @oilwellcbd

Monday-Thursday: 10am-7pm | Friday-Saturday: 10am-10pm | Sunday: 10am-4pm